Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis (Q45400777)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis |
scientific article |
Statements
1 reference
Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis (English)
1 reference
Naomi J Balamuth
1 reference
Kim E Nichols
1 reference
Michele Paessler
1 reference
David T Teachey
1 reference
1 August 2007
1 reference
1 reference
29
1 reference
8
1 reference
569-573
1 reference
Identifiers
1 reference
1 reference